The pan-PPAR agonist lanifibranor decreases portal pressure in models of both hepatic and prehepatic portal hypertension

Heldens, A; Casteleyn, C; Onghena, L; Antwi, M; Descamps, B; Vanhove, C; Verhelst, X; Van Vlierberghe, H; Devisscher, L; Junien, JL; Geerts, A; Wettstein, G; Lefere, S

JOURNAL OF HEPATOLOGY, 2023; 78 (): S226

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索